Skip to Main Content
Yale School of Medicine
About YSM
Faculty
Staff
Students
Residents & Fellows
Patients
Researchers
Alumni
Yale School of Medicine
/
FIB-SEM Collaboration Core (F-SCC)
MENU
Yale School of Medicine
MENU
FIB-SEM Collaboration Core (F-SCC)
Collaborations
News
People
Publications
Discoveries
YSM Home
INFORMATION FOR
About YSM
Faculty
Staff
Students
Residents & Fellows
Patients
Researchers
Alumni
Popular Links
Search
6 results
Refine
People (19237)
Web Pages (12542)
Documents (6941)
News (53001)
Events (27581)
Media (2878)
Clinical Trials (641)
Gender
Male (1)
Female (1)
Accept Healthy Volunteers
Yes (0)
No (0)
Categories
Addictive Behavior (0)
Aging (0)
Alcohol Addiction (0)
Alzheimer's (0)
Arthritis (0)
Asthma (0)
Autism (0)
Blood Disorders (0)
Brain & Spinal Cord & Nervous System (0)
Cancer (8)
Bladder (0)
Brain (0)
Breast (0)
Colorectal (0)
Gynecological (0)
Head and Neck (0)
Kidney (0)
Leukemia (6)
Liver (0)
Lung (1)
Lymphoma (2)
Melanoma (0)
Myeloma (0)
Non-Therapeutic (0)
Other Cancers (0)
Pancreas (0)
Pediatric Cancers (0)
Phase 1 (0)
Prevention (0)
Prostate (0)
Sarcoma (0)
Stomach and Esophagus (0)
Supportive Care (0)
Thyroid (0)
Children Health (0)
COVID-19 (0)
Diabetes (0)
Digestive System (0)
Diseases of the Respiratory Systems (0)
Endocrine System (0)
Genetics (0)
Headaches (0)
Hearing/Ear (0)
Heart/Cardiovascular (0)
Hepatitis (0)
HIV/AIDS (0)
Immune System (0)
Infants & Newborns (0)
Infectious Disease (0)
Kidney & Urinary Tract (0)
Liver (0)
Lung (0)
Men Health (0)
Mental Health & Behavioral Research (0)
Muscle & Bone (0)
Obesity & Weight Management (0)
Pain Control (0)
Poisoning/Injury (0)
Pregnancy and Obstetrics (0)
Sickle Cell (0)
Skin/Dermatology (0)
Sleep Disorders (0)
Tobacco Addiction (0)
Vision/Eye (0)
Women Health (0)
Status
New (0)
IRB Initial Approval (0)
PRC Approval (0)
Project Manager Signoff (0)
Open to Accrual (6)
Closed to Accrual (0)
For Affiliates Only (0)
IRB Study Closure (0)
Age
Select a year
Select a year
Less than 1 year
1 year
2 years
3 years
4 years
5 years
6 years
7 years
8 years
9 years
10 years
11 years
12 years
13 years
14 years
15 years
16 years
17 years
18 years
19 years
20 years
21 years
22 years
23 years
24 years
25 years
26 years
27 years
28 years
29 years
30 years
31 years
32 years
33 years
34 years
35 years
36 years
37 years
38 years
39 years
40 years
41 years
42 years
43 years
44 years
45 years
46 years
47 years
48 years
49 years
50 years
51 years
52 years
53 years
54 years
55 years
56 years
57 years
58 years
59 years
60 years
61 years
62 years
63 years
64 years
65 years
66 years
67 years
68 years
69 years
70 years
71 years
72 years
73 years
74 years
75 years
76 years
77 years
78 years
79 years
80 years
81 years
82 years
83 years
84 years
85 years
86 years
87 years
88 years
89 years
90 years
Search
Profile
Amer Zeidan
Clear
Search
Showing 6 results
in 'Clinical Trials'
Clinical Trials
Leukemia
Amer Zeidan
Clinical Trial
A Phase IB/II Study of Venetoclax (ABT-199) in Combination With Liposomal Vincristine in Patients With Relapsed or Refractory T-Cell or B-Cell Acute Lymphoblastic Leukemia
Both / 18+ years
Clinical Trial
A Randomized, Double-blind, Placebo-controlled Phase 3 Study of Tamibarotene Plus Azacitidine Versus Placebo Plus Azacitidine in Newly Diagnosed, Adult Patients Selected for RARA-positive Higher-risk Myelodysplastic Syndrome (SELECT MDS-1)
Clinical Trial
An Open-Label Phase 1a/1b Dose Escalation and Expansion Cohort Study of SL-172154 (SIRPα-Fc-CD40L) in Combination With Azacitidine or With Azacitidine and Venetoclax for the Treatment of Subjects With Higher-Risk Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML)
Clinical Trial
BLockade of PD-1 Added to Standard Therapy to Target Measurable Residual Disease in Acute Myeloid Leukemia 1 (BLAST MRD AML-1): A Randomized Phase 2 Study of the Anti-PD-1 Antibody Pembrolizumab in Combination With Conventional Intensive Chemotherapy as Frontline Therapy in Patients With Acute Myeloid Leukemia
Clinical Trial
Managed Access Program (MAP) to Provide Access to CTL019, for ALL or DLBCL Patients With Out of Specification Leukapheresis Product and/or Manufactured Tisagenlecleucel Out of Specification for Commercial Release
Clinical Trial
Phase II Study of Adding the Anti-PD-1 Pembrolizumab to Tyrosine Kinase Inhibitors in Patients With Chronic Myeloid Leukemia and Persistently Detectable Minimal Residual Disease
Your browser is antiquated and no longer supported on this website. Please update your browser or switch to Chrome, Firefox or Safari.
You can update your IE here:
https://support.microsoft.com/en-us/help/17621/internet-explorer-downloads
[7640,9243,2243,2317,8261,8480,8766,2324,3053]
{"namedChunks":["modules-page-components-ComponentWrapper","modules-search-components-global-search-GlobalSearchContainer","modules-footer-components-Footer"]}